Alex Beatson

Founder

Now Founder, Axiom Bio

Latest on AI4S.fyiTimeline · Feb 6Counting the cells a compound leaves alive predicts popular bioactivity benchmarks about as well as Cell Painting models, because many of their assays measure cell death

Account links back to axi.om · Avatar from their X account, taken 2026-09-28

Affiliations

Current

Founder · Axiom Bioamplifypartners.com ↗

Current roles come from these dated records, not from the bio below. Each links the page it was read from.

About

Alex Beatson is co-founder and chief technology officer of Axiom, which builds AI models to predict drug toxicity. Its investor Amplify Partners says he and co-founder Brandon White have published at the meeting of machine learning and computational biology and built tools at companies including Freenome, Spring Discovery, Genesis Therapeutics and Redesign Science.

Read on 2026-09-29; for current roles see Affiliations above. Read at: amplifypartners.com ↗

Founded

Axiom BioDrug discovery · 2 rounds on record · disclosed $15M · Round (unnamed) $8M
Background: ML for life sciences (CTO) (as the company's own announcements put it)
Co-founders: Brandon White
Backed byAmplify Partners

On the timeline

2026-02-06Counting the cells a compound leaves alive predicts popular bioactivity benchmarks about as well as Cell Painting models, because many of their assays measure cell death

Something wrong or missing on this page? Tell me and it will be fixed or removed. Contact →